Formosa Laboratories, Inc.
TWSE:4746.TW
67.2 (TWD) • At close July 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,731.046 | 4,360.448 | 3,765.504 | 3,142.406 | 3,075.457 | 2,759.591 | 2,687.731 | 2,539.353 | 3,189.38 | 2,596.722 | 2,496.224 | 2,473.633 | 2,524.282 | 2,625.647 | 2,505.914 | 0 |
| Cost of Revenue
| 2,682.33 | 2,437.119 | 2,375.312 | 2,170.962 | 2,130.287 | 1,934.327 | 1,773.614 | 1,533.531 | 1,931.94 | 1,790.732 | 1,809.538 | 2,134.318 | 2,133.07 | 2,040.413 | 1,907.966 | 0 |
| Gross Profit
| 2,048.716 | 1,923.329 | 1,390.192 | 971.444 | 945.17 | 825.264 | 914.117 | 1,005.822 | 1,257.44 | 805.99 | 686.686 | 339.315 | 391.212 | 585.234 | 597.948 | 0 |
| Gross Profit Ratio
| 0.433 | 0.441 | 0.369 | 0.309 | 0.307 | 0.299 | 0.34 | 0.396 | 0.394 | 0.31 | 0.275 | 0.137 | 0.155 | 0.223 | 0.239 | 0 |
| Reseach & Development Expenses
| 796.424 | 841.872 | 777.016 | 700.198 | 548.184 | 446.383 | 458.975 | 294.55 | 271.823 | 208.975 | 179.557 | 194.284 | 172.295 | 141.562 | 101.689 | 0 |
| General & Administrative Expenses
| 289.118 | 245.173 | 234.219 | 282.214 | 203.041 | 197.737 | 182.286 | 163.187 | 152.253 | 131.695 | 115.177 | 110.031 | 104.969 | 110.997 | 91.02 | 0 |
| Selling & Marketing Expenses
| 213.137 | 187.772 | 187.12 | 170.921 | 135.204 | 147.419 | 215.626 | 169.888 | 169.942 | 139.746 | 118.005 | 110.046 | 76.969 | 88.753 | 83.948 | 0 |
| SG&A
| 502.255 | 432.945 | 421.339 | 453.135 | 338.245 | 345.156 | 397.912 | 333.075 | 322.195 | 271.441 | 233.182 | 220.077 | 181.938 | 199.75 | 174.968 | 0 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 1,298.679 | 1,248.354 | 1,198.355 | 1,153.333 | 886.429 | 791.539 | 856.887 | 627.625 | 594.018 | 480.416 | 412.739 | 414.361 | 354.233 | 341.312 | 276.657 | 0 |
| Operating Income
| 750.037 | 674.975 | 380.848 | 1,101.705 | 420.416 | -2.21 | 57.23 | 378.197 | 663.422 | 325.574 | 273.947 | -75.046 | 36.979 | 243.922 | 321.291 | 0 |
| Operating Income Ratio
| 0.159 | 0.155 | 0.101 | 0.351 | 0.137 | -0.001 | 0.021 | 0.149 | 0.208 | 0.125 | 0.11 | -0.03 | 0.015 | 0.093 | 0.128 | 0 |
| Total Other Income Expenses Net
| -551.886 | -532.584 | -47.667 | 1,255.543 | 333.155 | -64.644 | 89.743 | -66.888 | -51.105 | 18.258 | 35.897 | 16.658 | -15.61 | 11.65 | -36.142 | 0 |
| Income Before Tax
| 198.151 | 142.391 | 333.181 | 1,087.526 | 361.168 | -40.206 | 146.973 | 311.309 | 612.317 | 343.832 | 309.844 | -58.388 | 21.369 | 254.893 | 285.149 | 0 |
| Income Before Tax Ratio
| 0.042 | 0.033 | 0.088 | 0.346 | 0.117 | -0.015 | 0.055 | 0.123 | 0.192 | 0.132 | 0.124 | -0.024 | 0.008 | 0.097 | 0.114 | 0 |
| Income Tax Expense
| 134.075 | 194.65 | 116.371 | 44.008 | 31.99 | 0.856 | 22.316 | 76.104 | 128.876 | 61.44 | 47.349 | 11.013 | 16.366 | 23.826 | 38.528 | 0 |
| Net Income
| 157.268 | 126.243 | 216.81 | 1,249.096 | 400.034 | -41.062 | 176.821 | 238.645 | 483.441 | 282.392 | 262.495 | -69.401 | 5.003 | 231.067 | 246.621 | 0 |
| Net Income Ratio
| 0.033 | 0.029 | 0.058 | 0.397 | 0.13 | -0.015 | 0.066 | 0.094 | 0.152 | 0.109 | 0.105 | -0.028 | 0.002 | 0.088 | 0.098 | 0 |
| EPS
| 1.31 | 1.05 | 1.8 | 10.92 | 3.78 | -0.41 | 1.78 | 2.62 | 5.48 | 3.31 | 3.1 | -0.97 | 0.08 | 3.44 | 3.99 | 0 |
| EPS Diluted
| 1.3 | 1.05 | 1.79 | 10.32 | 3.46 | -0.41 | 1.73 | 2.55 | 5.21 | 3.09 | 2.97 | -0.97 | 0.08 | 3.43 | 3.95 | 0 |
| EBITDA
| 746.858 | 1,163.304 | 851.763 | 1,576.704 | 870.227 | 372.912 | 481.648 | 616.217 | 928.52 | 556.698 | 467.449 | 119.112 | 165.685 | 378.491 | 395.323 | 0 |
| EBITDA Ratio
| 0.158 | 0.267 | 0.226 | 0.502 | 0.283 | 0.135 | 0.179 | 0.243 | 0.291 | 0.214 | 0.187 | 0.048 | 0.066 | 0.144 | 0.158 | 0 |